Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|March 13, 2014
Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deploymentJohn M Harrold, Anson K AbrahamCancer Research|February 22, 2012
Combinatorial chemotherapeutic efficacy in non-Hodgkin lymphoma can be predicted by a signaling model of CD20 pharmacodynamicsJohn M Harrold, Robert M Straubinger, Donald E MagerPharmaceutical Research|March 17, 2010
Interspecies scaling of receptor-mediated pharmacokinetics and pharmacodynamics of type I interferonsLeonid Kagan, Anson K Abraham, John M Harrold, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 11, 2016
A cell-level model of pharmacodynamics-mediated drug dispositionWojciech Krzyzanski, John M Harrold, Liviawati S Wu, et al.The AAPS Journal|December 23, 2016
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic ModelingAbhinav Tiwari, Anson K Abraham, John M Harrold, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 1, 2024
Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteinsShufang Liu, Yingyi Li, Zhe Li, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005
Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenograftsJohn M Harrold, Julie L Eiseman, Erin Joseph, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 7, 2015
Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodiesVaishali L Chudasama, Anup Zutshi, Pratap Singh, et al.The Journal of Pharmacology and Experimental Therapeutics|October 29, 2009
Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor modelRong Zhou, Richard V Mazurchuk, Judith H Tamburlin, et al.Molecular Cancer Therapeutics|August 11, 2021
Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) MoleculeElizabeth Pham, Matthias Friedrich, Famke Aeffner, et al.Pageof 2